SCHEMBL3923489

SCHEMBL3923489

C[Si](C)(C)CCOCn1nc2c(CCO)cc(C(F)(F)F)cc2c1Br

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 4/20 0.38
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
ALOX5AP P20292 1/20 0.31
FEN1 P39748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2425206 0.91 DGAT1 (0.39) DGAT1ALOX5APFEN1
SCHEMBL2423940 0.88 DGAT1 (0.40) DGAT1ALOX5APFEN1
SCHEMBL3929309 0.85 DGAT1 (0.34) DGAT1
SCHEMBL2429523 0.83 DGAT1 (0.35) DGAT1
SCHEMBL2425986 0.82 DGAT1 (0.38) DGAT1ALOX5APFEN1
SCHEMBL2425401 0.81 DGAT1 (0.38) DGAT1ALOX5APFEN1
SCHEMBL3926529 0.77 IDO1 (0.36) DGAT1IDO1TDO2ALOX5APFEN1
SCHEMBL2426784 0.76 DGAT1 (0.34) DGAT1
SCHEMBL3935350 0.76 TACR1 (0.45)
SCHEMBL3937390 0.75 DGAT1 (0.33) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 WO disclosed